Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Erttmann

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Pediatric Hematology and Oncology|January 1, 1996
Early toxicity of intensified conditioning with etoposide combined with total body irradiation/cyclophosphamide or busulfan/cyclophosphamide in children undergoing autologous or allogeneic bone marrow transplantationM Horstmann, G Kroschke, M Stockschläder, et al.
Klinische Padiatrie|September 3, 1999
[Natural human IgM-antibodies in neuroblastoma therapy: preliminary findings of a phase I/II clinical trial]C Schmitt, K David, J Hiller, et al.
Medical and Pediatric Oncology|December 7, 2000
Population-based and controlled study to evaluate neuroblastoma screening at one year of age in Germany: interim resultsF H Schilling, F Berthold, R Erttmann, et al.
Cancer Research|August 14, 1999
Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigenK David, M W Ollert, C Vollmert, et al.
Klinische Padiatrie|May 1, 1981
[Presentation of the cooperative study COALL-80 on treatment of childhood ALL (author's transl)]K Winkler, E Matzke, S Caspers, et al.
Journal of Pediatric Surgery|June 1, 1995
Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma--a report from the German Cooperative Pediatric Liver Tumor Study HB-89D von Schweinitz, H Hecker, D Harms, et al.
Lancet (London, England)|October 22, 1994
Screening for neuroblastomaF H Schilling, R Erttmann, P F Ambros, et al.
Anticancer Research|January 1, 1997
Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experienceH T Hassan, C Krog, M Stockschläder, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1991
Neuroblastoma screening: arguments from retrospective analysis of three German neuroblastoma trialsF Berthold, D H Hunneman, H Käser, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and HaematologyD von Schweinitz, D J Byrd, H Hecker, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Pediatric Hematology and Oncology|January 1, 1996
Early toxicity of intensified conditioning with etoposide combined with total body irradiation/cyclophosphamide or busulfan/cyclophosphamide in children undergoing autologous or allogeneic bone marrow transplantationM Horstmann, G Kroschke, M Stockschläder, et al.
Klinische Padiatrie|September 3, 1999
[Natural human IgM-antibodies in neuroblastoma therapy: preliminary findings of a phase I/II clinical trial]C Schmitt, K David, J Hiller, et al.
Medical and Pediatric Oncology|December 7, 2000
Population-based and controlled study to evaluate neuroblastoma screening at one year of age in Germany: interim resultsF H Schilling, F Berthold, R Erttmann, et al.
Cancer Research|August 14, 1999
Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigenK David, M W Ollert, C Vollmert, et al.
Klinische Padiatrie|May 1, 1981
[Presentation of the cooperative study COALL-80 on treatment of childhood ALL (author's transl)]K Winkler, E Matzke, S Caspers, et al.
Journal of Pediatric Surgery|June 1, 1995
Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma--a report from the German Cooperative Pediatric Liver Tumor Study HB-89D von Schweinitz, H Hecker, D Harms, et al.
Lancet (London, England)|October 22, 1994
Screening for neuroblastomaF H Schilling, R Erttmann, P F Ambros, et al.
Anticancer Research|January 1, 1997
Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experienceH T Hassan, C Krog, M Stockschläder, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1991
Neuroblastoma screening: arguments from retrospective analysis of three German neuroblastoma trialsF Berthold, D H Hunneman, H Käser, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and HaematologyD von Schweinitz, D J Byrd, H Hecker, et al.
Pageof 9